Members Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15M | Buy |
212,296
+5,351
| +3% | +$130K | 1.93% | 17 |
|
|
2025
Q1 | $5.24M | Buy |
206,945
+2,212
| +1% | +$56.1K | 2.19% | 14 |
|
|
2024
Q4 | $5.44M | Buy |
204,733
+82,691
| +68% | +$2.2M | 2.23% | 15 |
|
|
2024
Q3 | $3.53M | Buy |
122,042
+40,269
| +49% | +$1.17M | 1.77% | 13 |
|
|
2024
Q2 | $2.29M | Buy |
81,773
+60,722
| +288% | +$1.7M | 1.25% | 13 |
|
|
2024
Q1 | $584K | Buy |
+21,051
| New | +$584K | 0.33% | 15 |
|
|
2022
Q1 | – | Sell |
-3,579
| Closed | -$211K | – | 22 |
|
|
2021
Q4 | $211K | Buy |
+3,579
| New | +$211K | 0.14% | 21 |
|